# Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.

> **NCT01644305** · — · COMPLETED · sponsor: **Ankara Education and Research Hospital** · enrollment: 85 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01644305
- **Lead sponsor:** Ankara Education and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01644305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01644305, "Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01644305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*